RankingsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Earnings per share

ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】

Market cap
¥608.6B
P/E ratio
18.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2025136.1+0.37%
Mar 31, 2024135.6+17.29%
Mar 31, 2023115.6-37.25%
Mar 31, 2022184.3+25.53%
Mar 31, 2021146.8+8.62%
Mar 31, 2020135.1+57.13%
Mar 31, 201986+5.46%
Mar 31, 201881.6-7.28%
Mar 31, 201788+9.88%
Mar 31, 201680+5.25%
Mar 31, 201576.1-1.43%
Mar 31, 201477.2+12.17%
Mar 31, 201368.8-1.18%
Mar 31, 201269.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)